Paul Hastings LLP, Corporate/M&A & Private Equity

Chambers Review

Provided by Chambers

Corporate/M&A - Asia-Pacific Region

Band 4

What the Team is Known For

Paul Hastings has a notable corporate practice advising an impressive portfolio of Chinese clients from its Beijing, Shanghai and Hong Kong offices. The firm is renowned for its expertise in outbound private equity and real estate transactions and is regularly active on M&A, corporate restructurings, joint ventures and take-privates in the TMT sector, with additional experience across the life sciences, transportation, shipping and energy sectors. It advises on private equity deals for a client roster featuring Chinese and international private equity houses and funds, and remains highly focused on private equity investments in the real estate sector, with capacity to advise throughout Asia.

Notable practitioners

Shanghai-based David Wang and Yan Jia are key contacts for the group in Mainland China, while Raymond Li and Vivian Lam are key contacts in Hong Kong.

View ranking table

Work Highlights

Provided by Paul Hastings LLP

Paul Hastings advised SJL Partners and SD Biosensor on a merger agreement to acquire Meridian Bioscience, a Nasdaq-listed company, in an all-cash transaction for USD1.53 billion.
Paul Hastings advised Bain Gamma on successfully closing its approximately USD90 million Series A financing.
Paul Hastings advised Beijing Shouhuan on the establishment of the Beijing Universal Resort, which is home to Universal Studios Beijing, Universal Citiwalk Beijing and two hotels.

Strengths

Provided by Chambers

"Paul Hastings shows an excellent balance between securing the necessary legal protections and commercially moving negotiations forward."